Regeneron Pharmaceuticals, Inc. - stock earnings
REGN Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | 9.55 / 10.25 | - | 3.1 billion / 3.3 billion | - |
| Aug. 1, 2024 BeforeMarket | - / - | 3.2 billion | - / 3.4 billion | 3.6 billion |
REGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 722.0 million USD | 3.1 billion USD |
| 2023Q4 | 1.2 billion USD | 3.4 billion USD |
| 2023Q3 | 1.0 billion USD | 3.4 billion USD |
| 2023Q2 | 968.4 million USD | 3.2 billion USD |
| 2023Q1 | 817.8 million USD | 3.2 billion USD |
| 2022Q4 | 1.2 billion USD | 3.4 billion USD |
| 2022Q3 | 1.3 billion USD | 2.9 billion USD |
| 2022Q2 | 852.1 million USD | 2.9 billion USD |
| 2022Q1 | 973.5 million USD | 3.0 billion USD |
| 2021Q4 | 2.2 billion USD | 5.0 billion USD |
| 2021Q3 | 1.6 billion USD | 3.5 billion USD |
| 2021Q2 | 3.1 billion USD | 5.1 billion USD |
| 2021Q1 | 1.1 billion USD | 2.5 billion USD |
| 2020Q4 | 1.1 billion USD | 2.4 billion USD |
| 2020Q3 | 842.1 million USD | 2.3 billion USD |
| 2020Q2 | 897.3 million USD | 2.0 billion USD |
| 2020Q1 | 624.6 million USD | 1.8 billion USD |
| 2019Q4 | 792.0 million USD | 2.2 billion USD |
| 2019Q3 | 669.6 million USD | 2.0 billion USD |
| 2019Q2 | 193.1 million USD | 1.9 billion USD |
| 2019Q1 | 461.1 million USD | 1.7 billion USD |
| 2018Q4 | 820.4 million USD | 1.9 billion USD |
| 2018Q3 | 594.7 million USD | 1.7 billion USD |
| 2018Q2 | 551.4 million USD | 1.6 billion USD |
| 2018Q1 | 478.0 million USD | 1.5 billion USD |
| 2017Q4 | 173.5 million USD | 1.6 billion USD |
| 2017Q3 | 388.3 million USD | 1.5 billion USD |
| 2017Q2 | 387.7 million USD | 1.5 billion USD |
| 2017Q1 | 248.9 million USD | 1.3 billion USD |
| 2016Q4 | 253.1 million USD | 1.2 billion USD |
| 2016Q3 | 264.8 million USD | 1.2 billion USD |
| 2016Q2 | 196.2 million USD | 1.2 billion USD |
| 2016Q1 | 165.7 million USD | 1.2 billion USD |
| 2015Q4 | 155.0 million USD | 1.1 billion USD |
| 2015Q3 | 210.4 million USD | 1.1 billion USD |
| 2015Q2 | 194.6 million USD | 998.6 million USD |
| 2015Q1 | 76.0 million USD | 869.6 million USD |
| 2014Q4 | 110.2 million USD | 802.3 million USD |
| 2014Q3 | 79.7 million USD | 725.8 million USD |
| 2014Q2 | 92.7 million USD | 665.7 million USD |
| 2014Q1 | 65.4 million USD | 625.7 million USD |
| 2013Q4 | 96.8 million USD | 610.4 million USD |
| 2013Q3 | 141.3 million USD | 597.0 million USD |
| 2013Q2 | 87.4 million USD | 457.6 million USD |
| 2013Q1 | 98.9 million USD | 439.7 million USD |
| 2012Q4 | 470.4 million USD | 414.6 million USD |
| 2012Q3 | 191.5 million USD | 427.7 million USD |
| 2012Q2 | 76.7 million USD | 304.4 million USD |
| 2012Q1 | 11.7 million USD | 231.8 million USD |
| 2011Q4 | -53.4 million USD | 123.0 million USD |
| 2011Q3 | -62.4 million USD | 102.8 million USD |
| 2011Q2 | -62.5 million USD | 107.8 million USD |
| 2011Q1 | -43.4 million USD | 112.2 million USD |
| 2010Q4 | -14.6 million USD | 133.7 million USD |
| 2010Q3 | -33.9 million USD | 106.0 million USD |
| 2010Q2 | -25.5 million USD | 115.9 million USD |
| 2010Q1 | -30.5 million USD | 103.5 million USD |
| 2009Q4 | -36.5 million USD | 96.8 million USD |
| 2009Q3 | -1.0 million USD | 117.5 million USD |
| 2009Q2 | -14.9 million USD | 90.0 million USD |
| 2009Q1 | -17.5 million USD | 75.0 million USD |
| 2008Q4 | -31.5 million USD | 55.8 million USD |
| 2008Q3 | -21.1 million USD | 65.6 million USD |
| 2008Q2 | -18.5 million USD | 60.7 million USD |
| 2008Q1 | -11.6 million USD | 56.4 million USD |
| 2007Q4 | -13.1 million USD | 64.7 million USD |
| 2007Q3 | -35.8 million USD | 22.3 million USD |
| 2007Q2 | -26.8 million USD | 22.2 million USD |
| 2007Q1 | -29.9 million USD | 15.8 million USD |
| 2006Q4 | -31.0 million USD | 10.3 million USD |
| 2006Q3 | -27.4 million USD | 15.6 million USD |
| 2006Q2 | -23.6 million USD | 19.3 million USD |
| 2006Q1 | -20.4 million USD | 18.2 million USD |
| 2005Q4 | -29.7 million USD | 17.4 million USD |
| 2005Q3 | -34.7 million USD | 16.2 million USD |
| 2005Q2 | -27.0 million USD | 16.4 million USD |
| 2005Q1 | -4.1 million USD | 16.2 million USD |
| 2004Q4 | 2.8 million USD | 47.1 million USD |
| 2004Q3 | -11.1 million USD | 36.5 million USD |
| 2004Q2 | -14.5 million USD | 28.4 million USD |
| 2004Q1 | 64.5 million USD | 62.0 million USD |
| 2003Q4 | -19.4 million USD | 21.3 million USD |
| 2003Q3 | -27.4 million USD | 17.4 million USD |
| 2003Q2 | -28.7 million USD | 10.5 million USD |
| 2003Q1 | -30.1 million USD | 10.1 million USD |
| 2002Q4 | -35.7 million USD | 4.9 million USD |
| 2002Q3 | -32.8 million USD | 6.6 million USD |
| 2002Q2 | -30.4 million USD | 5.6 million USD |
| 2002Q1 | -25.4 million USD | 4.9 million USD |
| 2001Q4 | -28.4 million USD | 4.4 million USD |
| 2001Q3 | -19.9 million USD | 5.5 million USD |
| 2001Q2 | -14.8 million USD | 5.8 million USD |
| 2001Q1 | -13.0 million USD | 9.1 million USD |
| 2000Q4 | -9.7 million USD | 19.4 million USD |
| 2000Q3 | -3.2 million USD | 14.9 million USD |
| 2000Q2 | -2.9 million USD | 14.5 million USD |
| 2000Q1 | -7.3 million USD | 10.5 million USD |
| 1999Q4 | -1.4 million USD | 11.9 million USD |
| 1999Q3 | -4.9 million USD | 11.3 million USD |
| 1999Q2 | -7.8 million USD | 5.9 million USD |
| 1999Q1 | -8.9 million USD | 5.5 million USD |
| 1998Q4 | -5.5 million USD | 7.4 million USD |
| 1998Q3 | -1.4 million USD | 10.8 million USD |
| 1998Q2 | 2.1 million USD | 13.5 million USD |
| 1998Q1 | -3.8 million USD | 6.5 million USD |
| 1997Q4 | 500000 USD | 11.4 million USD |
| 1997Q3 | -1.9 million USD | 8.9 million USD |
| 1997Q2 | -4.3 million USD | 6.6 million USD |
| 1997Q1 | -5.9 million USD | 6.2 million USD |
| 1996Q4 | -8.1 million USD | 6.5 million USD |
| 1996Q3 | -8.9 million USD | 6.2 million USD |
| 1996Q2 | -7.6 million USD | 6.2 million USD |
| 1996Q1 | -7.8 million USD | 5.2 million USD |
| 1995Q4 | -7.8 million USD | 5.8 million USD |
| 1995Q3 | -7.1 million USD | 6.2 million USD |
| 1995Q2 | -4.4 million USD | 7.6 million USD |
| 1995Q1 | -4.2 million USD | 6.9 million USD |
| 1994Q4 | -5.8 million USD | 7.7 million USD |
| 1994Q3 | -4.0 million USD | 8.9 million USD |
| 1994Q2 | -10.2 million USD | 3.6 million USD |
| 1994Q1 | -10.7 million USD | 3.0 million USD |
| 1993Q4 | -11.5 million USD | 2.9 million USD |
| 1993Q3 | -9.6 million USD | 3.6 million USD |
| 1993Q2 | -9.4 million USD | 1.3 million USD |
| 1993Q1 | -9.3 million USD | 2.1 million USD |
| 1992Q4 | -6.4 million USD | 2.3 million USD |
| 1992Q3 | -5.8 million USD | 2.4 million USD |
| 1992Q2 | -3.7 million USD | 3.2 million USD |
| 1992Q1 | -3.3 million USD | 3.5 million USD |
| 1991Q4 | -2.1 million USD | 2.0 million USD |
| 1991Q3 | -900000 USD | 1.9 million USD |
| 1991Q2 | -300000 USD | 1.7 million USD |
| 1991Q1 | ? USD | 2.0 million USD |
| 1990Q4 | ? USD | 1.3 million USD |
| 1990Q3 | ? USD | 1.3 million USD |
| 1990Q2 | ? USD | 1.2 million USD |
| 1990Q1 | ? USD | 1.2 million USD |
REGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.0 billion USD | 13.1 billion USD |
| 2022 | 4.3 billion USD | 12.2 billion USD |
| 2021 | 8.1 billion USD | 16.1 billion USD |
| 2020 | 3.5 billion USD | 8.5 billion USD |
| 2019 | 2.1 billion USD | 7.9 billion USD |
| 2018 | 2.4 billion USD | 6.7 billion USD |
| 2017 | 1.2 billion USD | 5.9 billion USD |
| 2016 | 895.5 million USD | 4.9 billion USD |
| 2015 | 636.1 million USD | 4.1 billion USD |
| 2014 | 348.1 million USD | 2.8 billion USD |
| 2013 | 424.4 million USD | 2.1 billion USD |
| 2012 | 750.3 million USD | 1.4 billion USD |
| 2011 | -221.8 million USD | 445.8 million USD |
| 2010 | -104.5 million USD | 459.1 million USD |
| 2009 | -67.8 million USD | 379.3 million USD |
| 2008 | -82.7 million USD | 238.5 million USD |
| 2007 | -105.6 million USD | 125.0 million USD |
| 2006 | -102.3 million USD | 63.4 million USD |
| 2005 | -95.4 million USD | 66.2 million USD |
| 2004 | 41.7 million USD | 174.0 million USD |
| 2003 | -107.5 million USD | 57.5 million USD |
| 2002 | -124.4 million USD | 22.0 million USD |
| 2001 | -76.2 million USD | 22.0 million USD |
| 2000 | -23.2 million USD | 59.3 million USD |
| 1999 | -23.1 million USD | 34.5 million USD |
| 1998 | -8.6 million USD | 38.2 million USD |
| 1997 | -11.6 million USD | 33.1 million USD |
| 1996 | -32.4 million USD | 24.1 million USD |
| 1995 | -23.5 million USD | 27.4 million USD |
| 1994 | -30.7 million USD | 23.2 million USD |
| 1993 | -39.9 million USD | 10.6 million USD |
| 1992 | -19.1 million USD | 11.5 million USD |
| 1991 | -4.5 million USD | 7.3 million USD |
| 1990 | -3.3 million USD | 5.0 million USD |
REGN
Price: $957
52 week price:
Earnings Per Share: 34.76 USD
P/E Ratio: 27.12
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 417600
Ebitda: 597.4 millionMarket Capitalization: 105.4 billion